Issy-les-Moulineaux, France

Philippe Jais

This inventor holds 1 USPTO granted patent. Top assignee: Serono Genetics Institute S.a.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philippe Jais. Retrieved from https://idiyas.com/inventor/philippe-jais-taoz1vwe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Philippe Jais in GlyT1 Transporter Research

Introduction

Philippe Jais is a notable inventor based in Issy-les-Moulineaux, France. He has made significant contributions to the field of biotechnology, particularly in the study of the GlyT1 transporter. His work focuses on the development of novel therapeutic approaches for neurological and psychiatric disorders.

Latest Patents

Philippe Jais holds a patent for "Variants and exons of the GlyT1 transporter." This invention provides polypeptide and polynucleotide sequences for novel splice variants of the sodium and chloride-dependent glycine transporter type 1 (GlyT1). These polypeptides and polynucleotides are useful in the treatment and diagnosis of disorders such as schizophrenia. The invention also includes antibodies specifically directed against these novel polypeptides, along with kits comprising the described polynucleotides, polypeptides, and/or antibodies. He has 1 patent to his name.

Career Highlights

Philippe Jais is associated with the Serono Genetics Institute S.A., where he continues to advance research in his field. His work has implications for understanding and treating complex neurological conditions.

Collaborations

He has collaborated with notable colleagues such as Gilbert Thill and Pascale Grel, contributing to a dynamic research environment that fosters innovation.

Conclusion

Philippe Jais's contributions to the field of glycine transporter research highlight the importance of innovation in addressing neurological disorders. His work exemplifies the potential of biotechnology to improve diagnosis and treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…